Updated Analysis of KEYNOTE-024: Pembrolizumab vs Platinum-Based Chemotherapy for Advanced NSCLC With PD-L1 TPS ≥50%

被引：26

作者：

Brahmer, J. ^{[1
]}

Rodriguez-Abreu, D. ^{[2
]}

Robinson, A. ^{[3
]}

Hui, R. ^{[4
,5
]}

Csoszi, T. ^{[6
]}

Fulop, A. ^{[7
]}

Gottfried, M. ^{[8
,9
]}

Peled, N. ^{[10
]}

Tafreshi, A. ^{[11
]}

Cuffe, S. ^{[12
]}

O'Brien, M. ^{[13
]}

Rao, S. ^{[14
,15
]}

Hotta, K. ^{[16
]}

Riccio, A. ^{[17
]}

Yang, J. ^{[17
]}

Pietanza, M. C. ^{[17
]}

Reck, M. ^{[18
]}

机构：

[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Med Oncol, Baltimore, MD USA

[2] Hosp Univ Insular Gran Canaria, Med Oncol, Las Palmas Gran Canaria, Spain

[3] Ccr Ctr Southeastern Ontario, Kingston, ON, Canada

[4] Westmead Hosp, Dept Med Oncol, Sydney, NSW, Australia

[5] Univ Sydney, Sydney, NSW, Australia

[6] Jasz Nagykun Szolnok Cty Hosp, Szolnok, Hungary

[7] Orszagos Koranyi Pulmonol Int, Budapest, Hungary

[8] Meir Med Ctr, Oncol Dept, Lung Canc Unit, Kefar Sava, Israel

[9] Meir Med Ctr, Lung Canc Res Lab, Kefar Sava, Israel

[10] Tel Aviv Univ, Davidoff Canc Ctr, Petah Tiqwa, Israel

[11] Southern Med Day Care Ctr, Oncol, Wollongong, NSW, Australia

[12] St James Hosp, Thorac Oncol Res Grp, Dublin, Ireland

[13] Trinity Coll Dublin, Dublin, Ireland

[14] Royal Marsden Hosp, Med Oncol, Sutton, Surrey, England

[15] Medstar Franklin Sq Med Ctr, Baltimore, MD USA

[16] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan

[17] Merck & Co Inc, Clin Sci & Study Management, Kenilworth, NJ USA

[18] German Ctr Lung Res DZL, ACRN, Lung Clin Grosshansdorf, Grosshansdorf, Germany

来源：

JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期

关键词：

KEYNOTE-024; Non-small-cell lung cancer; pembrolizumab;

D O I：

10.1016/j.jtho.2017.09.431

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA 17.06

引用

页码：S1793 / S1794

页数：2